zumabdenosumab,

Giovanni Adami1, Elisa Pedrollo1, Maurizio Rossini1

  • 1Rheumatology Unit, Department of Medicine, University of Verona, Verona, 37134, Italy.

JBMR plus
|March 28, 2024
PubMed
概括

罗莫苏祖马布改善了绝经后骨质疏松症患者的骨矿物质密度 (BMD) 和骨形成标志物. 添加romosozumab与denosumab显示有好处,但需要进一步的试验.